More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
MJNA Well-Represented at My Compassion Cannabis Conference in Chicago

MJNA Well-Represented at My Compassion Cannabis Conference in Chicago

by adminAdrianRamirez | Jul 29, 2015 | Axim Biotechnologies, Company News, Media Coverage

Medical Marijuana Inc. portfolio companies and brands AXIM Biotechnologies, CanChew ® Gum and Real Scientific Hemp Oil ™ got the media spotlight this past weekend at Chicago’s My Compassion Cannabis Conference. Outlets from FOX, NBC, ABC and Telemundo, and...
Medical Marijuana, Inc. Defeats Project CBD’s Anti-SLAPP Motion and Motion to Reconsider in $100 Million False Claims Lawsuit

Medical Marijuana, Inc. Defeats Project CBD’s Anti-SLAPP Motion and Motion to Reconsider in $100 Million False Claims Lawsuit

by adminAdrianRamirez | Jul 28, 2015 | Company News, Press Releases

MJNA Moves Forward with Prosecuting Libel Claims Made Against the Company and Its Brands, Case Now in Discovery Phase SAN DIEGO, CA – July 28, 2015 — Medical Marijuana, Inc. (OTC Pink: MJNA) announced in October that it filed a $100 million lawsuit against...
MJNA Reaches Global Settlement of Pending Litigation with CannaVest

MJNA Reaches Global Settlement of Pending Litigation with CannaVest

by adminAdrianRamirez | Jul 22, 2015 | Cannabis Beauty Defined, Company News, Press Releases

MJNA CEO Lauds IP ‘Windfall’ in Brands Secured in Settlement, Along With ‘Significant Expense Removed’ SAN DIEGO, July 22, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is...
Real Scientific Hemp Oil (RSHO) Import Tax Waived by Brazilian Government

Real Scientific Hemp Oil (RSHO) Import Tax Waived by Brazilian Government

by adminAdrianRamirez | Jul 14, 2015 | HempMeds, HempMeds Brasil, Industry Updates, Press Releases

Latest Brazilian Government Ruling Eliminates Import Tax of MJNA’s CBD Hemp Oil Brands, Including Real Scientific Hemp Oil™ (RSHO™), with ANVISA Registration and Documentation SAN DIEGO, CA – July 14, 2015 – Medical Marijuana, Inc. (OTC Pink: MJNA), an industrial hemp...
Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies

Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies

by adminAdrianRamirez | Jul 1, 2015 | Axim Biotechnologies, Company News, Press Releases

Cutting-Edge Global Industrial Hemp-Based Biotechnology Company Brings Added Diversity in Food and Pharmaceuticals to MJNA’s Growing Investment Portfolio Medical Marijuana, Inc. (OTC Pink: MJNA) would like to inform the public and shareholders that it holds 14,943,650...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.